Navigation Links
BioLife Solutions Named One of Washington's Best Companies

BOTHELL, Wash., June 24, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTC:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced that it has been named by Seattle Business Magazine as one of the best places to work in Washington state.



Now in its 23rd year, this competition salutes Washington companies setting the standard for leadership, strong benefits, ideal work environment, innovative training, happiest employees and more.  Winners were recognized at an awards dinner held on June 20th at the Westin Hotel in Seattle.

Mike Rice, Chief Executive Officer, commented, "Our entire team is very honored and proud to receive this recognition.  It is gratifying to see our people and special corporate culture acknowledged within the Washington state business community.  We have built a very solid, high performance team that is the single greatest contributor to the success BioLife has achieved since the Company relocated to Bothell in early 2007.  I'm honored to have the opportunity to lead such a dedicated and capable team."

In 2012, BioLife doubled revenue over 2011, doubled the size of its workforce to nearly 30 team members, and firmly established its products as best in class, clinical grade biopreservation storage and freeze media for cells, tissues, and organs.  Shares of the Company have recently traded at nearly 10 times above a previous low price set in January 2011.

Rice continued, "BioLife is a very special place to work.  A requirement for teamwork and open and honest communication is a hallmark of our merit-based culture and a foundational principal of my management philosophy."

For the complete list of winning companies, please visit:

About BioLife SolutionsBioLife Solutions develops, manufactures and markets patented hypothermic storage and cryopreservation solutions for cells and tissues.  The Company's proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife's products are serum-free and protein-free, fully defined, and are formulated to reduce biopreservation-induced cell damage and death.  BioLife's enabling technology provides academic and clinical researchers, and commercial companies significant improvements in post-thaw cell, tissue, and organ viability and function.  For more information please visit, and follow BioLife on Twitter.

This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include any statements that relate to the intent, belief, plans or expectations of the Company or its management, or that are not a statement of historical fact.  Any forward-looking statements in this news release are based on current expectations and beliefs and are subject to numerous risks and uncertainties that could cause actual results to differ materially. Some of the specific factors that could cause BioLife Solutions' actual results to differ materially are discussed in the Company's recent filings with the Securities and Exchange Commission.  BioLife Solutions disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.  Media Relations:

Investor Relations:Len Hall

Matt ClawsonAllen & Caron Inc

Allen & Caron Inc(949) 474-4300


SOURCE BioLife Solutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of 2013
2. BioLife Solutions Announces License Agreement
3. BioLife Solutions Announces 2012 Third Quarter Results: Ninth Straight Quarter of Record Revenue
4. BioLife Solutions Announces Presentation at IBC Inaugural Cell Therapy Clinical Development Conference
5. BioLife Solutions Announces 2012 Second Quarter Results: Eighth Straight Quarter of Record Revenue
6. BioLife Solutions Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite
7. Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION
8. BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board
9. BioLife Solutions 2011 Revenue Up 33%
10. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
11. Accel-KKR Makes Growth Equity Investment in Zinc Ahead, Leading Provider of Marketing Compliance Solutions for the Life Sciences Industry
Post Your Comments:
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is ... projects are designed, built and brought to market. , The Design Lab is ...
(Date:6/23/2016)... June 23, 2016  Blueprint Bio, a company dedicated ... the medical community, has closed its Series A funding ... . "We have received a commitment from ... we need to meet our current goals," stated ... the runway to complete validation on the current projects ...
Breaking Biology Technology:
(Date:6/22/2016)... 22, 2016  The American College of Medical Genetics and ... Magazine as one of the fastest-growing trade shows during ... the Bellagio in Las Vegas . ... of growth in each of the following categories: net square ... number of attendees. The 2015 ACMG Annual Meeting was ranked ...
(Date:6/21/2016)... , June 21, 2016 NuData ... the new role of principal product architect and ... the director of customer development. Both will report ... technical officer. The moves reflect NuData,s strategic growth ... response to high customer demand and customer focus ...
(Date:6/15/2016)... York , June 15, 2016 ... new market report titled "Gesture Recognition Market by Application ... Forecast, 2016 - 2024". According to the report, the  ... 11.60 billion in 2015 and is estimated to ... USD 48.56 billion by 2024.  Increasing ...
Breaking Biology News(10 mins):